STUDY SEARCH RESULTS

1 study found for your search request:  7902-008

Efficacy and Safety of Pembrolizumab (MK-3475) with Lenvatinib (E7080/MK-7902) vs. Docetaxel in Part...
Condition: Metastatic Non-Small Cell Lung Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT03976375
Status: Active, not recruiting




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site